日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Efficacy and safety of Telitacicept in IgA nephropathy and its impact on urinary Gd-IgA1: insights from a real-world study

Telitacicept治疗IgA肾病的疗效和安全性及其对尿Gd-IgA1的影响:一项真实世界研究的启示

Li, Hongfen; Li, Wenying; Wang, Fanghao; Xing, Yue; Wu, Zhanfei; Jia, Junya; Liu, Youxia; Yan, Tiekun

The Efficacy and Safety of Enarodustat for the Treatment of Anemia in Hemodialysis-Dependent Chronic Kidney Disease Patients: A Phase 3, Multicenter, Randomized, Active-Comparator (Recombinant Human Erythropoietin), Open-Label Study - The ENARODIAL Study

Enarodustat治疗血液透析依赖型慢性肾脏病患者贫血的疗效和安全性:一项3期、多中心、随机、活性对照(重组人红细胞生成素)、开放标签研究——ENARODIAL研究

Wu, Haishan; Ai, Zhen; Liu, Aiying; Ye, Hong; Sun, Changyou; Yang, Aicheng; Chen, Wenli; Zheng, Zhihua; Wang, Caili; Li, Yuehong; Cao, Ning; Wang, Cheng; Xia, Yuou; Cheng, Hong; Luo, Ping; Yang, Qiongqiong; Yan, Yuehong; Zhou, Hua; Mao, Nan; Xiong, Zibo; Liu, Bicheng; Hong, Daqing; Chen, Qingping; Liang, Bo; Luo, Qun; Wang, Yu; Shi, Yongjun; Chen, Xiaonong; Zhou, Li; Yan, Tiekun; Zhu, Bin; Wang, Jianwen; Chen, Menghua; Zhu, Yongjun; Guan, Tianjun; Wang, Song; Mu, Shengmei; Chen, Yuanyuan; Lian, Xiaojuan; Liu, Zichen; Xu, Yuanwen; Chen, Wei

Treatment patterns, clinical outcomes, and economic burden among patients with immunoglobulin A nephropathy (IgAN) in China

中国免疫球蛋白A肾病(IgAN)患者的治疗模式、临床结果和经济负担

Liu, Youxia; Xing, Yue; Li, Hongfen; Qi, Yan; Nunna, Sasikiran; Chen, Zhaoxin; Zhuang, Yuelin; Zhang, Yilong; Lu, Wentian; Kou, Jiaqi; Lin, Xiaoyu; Zuo, Li; Yan, Tiekun

Lower vs . standard starting dose oral roxadustat for treating anemia in Chinese patients with chronic kidney disease on dialysis: A prospective, randomized clinical trial

低起始剂量与标准起始剂量口服罗沙司他治疗中国慢性肾脏病透析患者贫血的疗效比较:一项前瞻性随机临床试验

Tu, Yan; Xu, Yan; Yao, Li; Zhang, Beiru; Yan, Tiekun; Yin, Aiping; Zhang, Xinzhou; Yang, Min; Liu, Jun; Wang, Caili; Peng, Xiaomei; Wang, Jianqin; Niu, Wei; Jiang, Wenqing; Liu, Bi-Cheng

Enhanced Nutritional Support May Ameliorate Rivaroxaban-Related Rapid Renal Function Decline: New Insights from a Real-World Study

加强营养支持或可改善利伐沙班相关肾功能快速下降:一项真实世界研究的新发现

Meng, Cheng; Li, Linjie; Han, Ying; Zhang, Xinxin; Lin, Yujia; Liu, Hangkuan; Jiang, Shichen; Yan, Tiekun; Zhang, Lirong; Chang, Baocheng; Zhou, Xin; Jia, Junya

Unveiling the role of oxidative stress in ANCA-associated glomerulonephritis through integrated machine learning and bioinformatics analyses

通过整合机器学习和生物信息学分析揭示氧化应激在ANCA相关性肾小球肾炎中的作用

Xie, Liyuan; Qiu, Xianying; Jia, Junya; Yan, Tiekun; Xu, Pengcheng

The neutrophil-to-monocyte ratio: a superior inflammatory marker predicting poor prognosis in IgA nephropathy

中性粒细胞与单核细胞比值:预测IgA肾病预后不良的优良炎症标志物

Liu, Youxia; Yu, Huyan; Luo, Yi; Li, Hongfen; Wang, Fanghao; Xing, Yue; Wu, Zhanfei; Li, Wenying; Jia, Junya; Yan, Tiekun

Inhibition of Axl attenuates acute kidney injury by alleviating inflammation via SOCS3 downregulation in tubular epithelial cells.

抑制 Axl 可通过下调肾小管上皮细胞中的 SOCS3 来减轻炎症,从而减轻急性肾损伤

Kang Xin, Gu Qiuhua, Cheng Xi, Jia Junya, Yan Tiekun

Association of 25-Hydroxyvitamin D With Metabolic Dysfunction-Associated Fatty Liver Disease: Results From NHANES 2017-2018

25-羟基维生素D与代谢功能障碍相关脂肪肝疾病的关联:来自2017-2018年NHANES调查的结果

Rao, Xiaojuan; Zhang, Xinxin; Li, Shuo; Huang, Bo; Wang, Junhe; Cui, Jingqiu; Liu, Ming; Yan, Tiekun

Clinical and pathological findings of IgA nephropathy following SARS-CoV-2 infection

SARS-CoV-2感染后IgA肾病的临床和病理学发现

Li, Hongfen; Li, Zhao; Wu, Zhanfei; Wang, Fanghao; Xing, Yue; Liu, Youxia; Jia, Junya; Yan, Tiekun